David Reardon On Caring For Patients With Glioblastoma

David Reardon on Caring for Patients With Glioblastoma

Helping Patients with Brain Cancer: Dr. David Reardon

Dana-Farber Cancer Institute

Dr. David Reardon on Treating Glioblastoma Patients With EGFRvIII-Mutations

Targeted Oncology

ASCO22: Glioblastoma research by David Reardon, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Dr. David Reardon on Immunotherapy and Rindopepimut in the Glioblastoma Treatment Paradigm

Targeted Oncology

What is the Optimal Care Team for a Brain Tumor Patient?

Dana-Farber Cancer Institute

The Inadequacy of the Current Standard of Care for Glioblastoma

Targeted Oncology

Dr. Reardon on the Immunogenicity of Glioblastoma

Breaking Down Misconceptions about Glioblastoma

Dr. Reardon on the Need for a New Standard of Care in GBM

Aiming the Immune System at Brain Cancer, with David Reardon

Cancer Research Institute

Immunotherapy for Brain Cancer, with David Reardon

Cancer Research Institute

Advice for Newly Diagnosed Patients With GBM

Brain Cancer and Immunotherapy with Dr. David Reardon

Cancer Research Institute

Advancing Neuro-Oncology treatment: Dr. David Reardon | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Dr. Reardon on Pembrolizumab and Bevacizumab for Glioblastoma

What New Therapies are Available for Patients with Recurrent Glioblastoma?

Dana-Farber Cancer Institute

Dr. Reardon on Nivolumab/Ipilimumab in Glioblastoma

Dr. David Reardon on Targeting Brain Tumors and Monitoring Resistances

Targeted Oncology

What Can I Expect from a Vaccine Trial for Glioblastoma? Ask a Scientist

Cancer Research Institute